HEADACHES AND WOMEN - TREATMENT OF THE PREGNANT AND LACTATING MIGRAINEUR

被引：35

作者：

SILBERSTEIN, SD ^{[1
]}

机构：

[1] TEMPLE UNIV,SCH MED,PHILADELPHIA,PA 19144

来源：

HEADACHE | 1993年 / 33卷 / 10期

关键词：

MIGRAINE; PREGNANCY; LACTATION; TERATOGENICITY; ERGOTAMINE; SUMATRIPTAN;

D O I：

10.1111/j.1526-4610.1993.hed3310533.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Migraine is a hormonally sensitive episodic headache disorder which may worsen during the first trimester, but usually improves during later pregnancy. Its treatment can be difficult because of the risks of injury to the fetus and newborn. These risks include teratogenicity. embryo mortality, fatal growth abnormalities, end perinatal effect. This paper reviews the effects of drugs on the fetus and newborn, their FDA classification, and their use during both pregnancy and lactation. Specific recommendations are given.

引用

页码：533 / 540

页数：8

共 25 条

[1]

BARNHART ER, 1991, PHYSICIANS DESK REFE

[2]

Berde B., 1978, ERGOT ALKALOIDS RELA, P1, DOI DOI 10.1007/978-3-642-66775-6_1

[3] EFFECTS OF EXPOSURE TO BENZODIAZEPINE DURING FETAL LIFE [J].

BERGMAN, U ;

ROSA, FW ;

BAUM, C ;

WIHOLM, BE ;

FAICH, GA .

LANCET, 1992, 340 (8821) :694-696

[4]

BLAKE DA, 1988, DRUG USE PREGNANCY, P1

[5]

Briggs GG., 1990, DRUGS PREGNANCY LACT

[6] CLASSIFICATION AND TREATMENT OF HEADACHE DURING PREGNANCY [J].

DALESSIO, DJ .

CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) :121-131

[7]

FEATHERSTONE HJ, 1983, HEADACHE, V23, P213

[8]

Griffith R. W., 1978, ERGOT ALKALOIDS RELA, P805, DOI DOI 10.1007/978-3-642-66775-6_12

[9]

HEINONEN OP, 1977, BIRTH DEFECTS DRUG P

[10] BIRTH-DEFECTS FOLLOWING MATERNAL EXPOSURE TO ERGOTAMINE, BETA-BLOCKERS, AND CAFFEINE [J].

HUGHES, HE ;

GOLDSTEIN, DA .

JOURNAL OF MEDICAL GENETICS, 1988, 25 (06) :396-399

← 1 2 3 →